A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Diabetes Care - United States
doi 10.2337/diacare.28.7.1547
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

Pioglitazone and Rosiglitazone Have Different Effects on Serum Lipoprotein Particle Concentrations and Sizes in Patients With Type 2 Diabetes and Dyslipidemia

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus

Journal of Clinical Medicine Research
2018English

Glycaemic and Nonglycaemic Effects of Pioglitazone in Triple Oral Therapy of Patients With Type 2 Diabetes

Journal of Internal Medicine
Internal Medicine
2006English

Depression and Glycemic Control in a Sample of Patients With Type 2 Diabetes

MOJ Addiction Medicine & Therapy
2017English

Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy

Archives of Internal Medicine
2008English

Obesity and Poor Glycemic Control in Patients With Type 2 Diabetes

International Journal of Research in Medical Sciences
2016English

Comparison of Teneligliptin and Atorvastatin on Lipid Profile in Patients With Type 2 Diabetes Mellitus

Current Research in Diabetes & Obesity Journal
2018English

Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus

JAMA - Journal of the American Medical Association
Medicine
2000English

Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

JAMA - Journal of the American Medical Association
Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy